Michael Saylor: Strategy is buying a significant amount of bitcoin and will announce it next Monday

Investigation into Powell Concluded, Paving the Way for Walsh's Confirmation as Fed Chair, Rate Cut Expectations Rise

Biopharmaceutical company COMPASS Pathways plc announced that the U.S. Food and Drug Administration (FDA) has officially approved its request for rolling review of its New Drug Application (NDA), and has simultaneously granted a priority review voucher.

Nomura: Next week, the market will focus on the Bank of England policymakers' views on inflation and growth outlook.

Economists raise US inflation expectations and predict the Federal Reserve will cut interest rates only once this year